Abcodia has been judged one of the UK’s most innovative life science companies in a UK Trade & Investment competition, winning the opportunity to showcase its innovative work to an international audience at the BIO 2013 Convention in Chicago later this month.
The competition was open to UK SMEs in the life science sector with innovative technological ideas and four winners were selected, including Abcodia. The prize includes receiving up to £1,500 towards flights and accommodation for the conference on 22 – 25 April and one year’s free membership of the BioIndustry Association.
Mike Fisher, Abcodia’s Director of Strategic Alliances, said winning this competition demonstrates that its cutting edge work is at the forefront of today’s most innovative life science technology. He said:
“We are delighted to have been selected for this award. International collaboration is critically important for Abcodia and we believe that this opportunity will enable us to showcase our capability in biomarker validation for the early detection and screening of cancer to an international audience. We are honoured to be representing the
best of UK innovation.”
Nick Baird, Chief Executive of the UKTI, said: "The Innovation Competition has demonstrated the excellence of the UK life sciences sector. We are a global leader in this field and I am looking forward to the best of British innovation being showcased at the forthcoming BIO 2013 Convention."
Steve Bates, Chief Executive Officer of the BIA, said: “This new UKTI Innovation Competition has presented an opportunity for some of the UK’s most innovative life science SMEs to grow their business and showcase internationally what our biotech sector has to offer.
“With a track-record of ground-breaking research, and support from schemes including the Patent Box, R&D tax credits and the Biomedical Catalyst, the UK is increasingly attractive as a location for bioscience business. I’m really looking forward to attending BIO 2013 and promoting UK biotech on a global stage.”
The BIO conference is recognised as the largest biotechnology event in the world and in 2012 the event drew over 15,000 industry leaders from 65 countries, attracting top companies and government representatives from around the globe.